Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Income towards Parent Company: 2020-2025

Historic Income towards Parent Company for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to $90.2 million.

  • Pharming Group N.V's Income towards Parent Company rose 1255.41% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.8 million, marking a year-over-year increase of 495.63%. This contributed to the annual value of -$12.0 million for FY2024, which is 283.16% down from last year.
  • As of Q3 2025, Pharming Group N.V's Income towards Parent Company stood at $90.2 million, which was up 856.29% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Pharming Group N.V's Income towards Parent Company peaked at $90.2 million during Q3 2025, and registered a low of -$25.7 million during Q3 2021.
  • In the last 3 years, Pharming Group N.V's Income towards Parent Company had a median value of $3.4 million in 2023 and averaged $5.1 million.
  • As far as peak fluctuations go, Pharming Group N.V's Income towards Parent Company surged by 29,235.91% in 2022, and later tumbled by 463.64% in 2023.
  • Quarterly analysis of 5 years shows Pharming Group N.V's Income towards Parent Company stood at $5.7 million in 2021, then tumbled by 132.35% to -$1.8 million in 2022, then surged by 375.83% to $5.1 million in 2023, then grew by 28.20% to $6.5 million in 2024, then soared by 1,255.41% to $90.2 million in 2025.
  • Its Income towards Parent Company was $90.2 million in Q3 2025, compared to $9.4 million in Q2 2025 and $6.5 million in Q4 2024.